Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001526170 | SCV001736467 | uncertain significance | Cardiomyopathy | 2023-06-08 | criteria provided, single submitter | clinical testing | This missense variant replaces threonine with serine at codon 534 of the lamin A/C proteins. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with congenital muscular dystrophy (PMID: 28688748). This variant has been identified in 1/198866 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Invitae | RCV001873693 | SCV002314465 | uncertain significance | Charcot-Marie-Tooth disease type 2 | 2023-06-06 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on LMNA protein function. ClinVar contains an entry for this variant (Variation ID: 1172352). This missense change has been observed in individual(s) with clinical features of congenital muscular dystrophy (PMID: 28688748). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 534 of the LMNA protein (p.Thr534Ser). |
Ambry Genetics | RCV002405217 | SCV002708663 | uncertain significance | Cardiovascular phenotype | 2023-10-17 | criteria provided, single submitter | clinical testing | The p.T534S variant (also known as c.1601C>G), located in coding exon 9 of the LMNA gene, results from a C to G substitution at nucleotide position 1601. The threonine at codon 534 is replaced by serine, an amino acid with similar properties. This alteration has been reported in the heterozygous state in a proband with congenital muscular dystrophy phenotype (Sframeli M et al. Neuromuscul Disord, 2017 Sep;27:793-803). This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002495848 | SCV002791420 | uncertain significance | Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome; Dilated cardiomyopathy 1A; Charcot-Marie-Tooth disease type 2B1; Emery-Dreifuss muscular dystrophy 2, autosomal dominant; Heart-hand syndrome, Slovenian type; Hutchinson-Gilford syndrome; Familial partial lipodystrophy, Dunnigan type; Mandibuloacral dysplasia with type A lipodystrophy; Congenital muscular dystrophy due to LMNA mutation; Emery-Dreifuss muscular dystrophy 3, autosomal recessive; Restrictive dermopathy 2 | 2021-07-09 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003136095 | SCV003814693 | uncertain significance | not provided | 2019-05-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004008896 | SCV004818594 | uncertain significance | Primary dilated cardiomyopathy | 2023-08-15 | criteria provided, single submitter | clinical testing | This missense variant replaces threonine with serine at codon 534 of the lamin A/C proteins. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with congenital muscular dystrophy (PMID: 28688748). This variant has been identified in 1/198866 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |